Search

Issue
Title
Authors
Search for predictors of psoriatic arthritis in patients with psoriasis
Artamonova O.G., Karamova A.E., Kubanov A.A., Verbenko D.A., Kozlova I.V.
The role of cells of the innate immune system in psoriasis
Sorokina E.V., Bisheva I.V.
Experience of using ustekinumab in the treatment of a patient with HIV-associated psoriasis and anogenital warts
Babkova M.I., Arshinsky M.I., Frolova Z.V., Chudina O.A., Mitrofanova J.S., Batalova S.K.
Periods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry)
Kubanov A.A., Bogdanova E.V.
Resources and performance rates of medical organizations providing medical care in the field of dermatovenereology in the Russian Federation in 2016–2022
Kubanov A.A., Bogdanova E.V.
A prospective open-label study of the antifungal activity of external forms of activated zinc pyrithione in the treatment of Malassezia-associated skin diseases
Samtsov A.V., Patrushev A.V., Chepushtanova K.O., Bogdanova T.V., Alekssev A.Y., Bogomolova T.S., Vasilyeva N.V.
Anticytokine therapy with interleukin-17 in patients with moderate and severe psoriasis
Kovaleva J.S., Kazantsev I.V., Aibazova A.A., Ovchinnikova E.O., Garina A.A., Shabaldina A.P.
Langerhans cells and gamma delta Т-lymphocytes in the pathogenesis of psoriasis
Sorokina E.V., Kalinichenko E.O., Bisheva I.V., Stolpnikova V.N.
Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
Bogdanova E.V.
Revisiting the question of psoriasis classification
Karamova A.E., Olisova O.Y., Bakulev A.L., Kokhan M.M., Khairutdinov V.R., Sokolovskiy E.V., Khobeych M.M.
Predictive model and classification for psoriatic arthritis risk assessment for Russian patients with psoriasis (on registry data)
Bogdanova E.V.
Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab
Bakulev A.L., Kruglova L.S.
Skin microbiota in patients with psoriasis vulgaris and pustular psoriasis
Bakhlykova E.A., Filimonkova N.N., Timokhina T.K., Kurlovich N.A.
The peripheral blood regulatory T-cells analysis as a criterion for assessing the therapy efficacy and a prognostic marker for the duration of remission of psoriasis
Olisova O.Y., Gudova V.V.
Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial
Bakulev A.I., Samtsov A.V., Sokolovskiy E.V., Kokhan M.M., Khobeish M.M., Khairutdinov V.R., Karamova A.E., Olisova O.U., Ignatiev D.V., Nikiforova A.N., Artemeva A.V., Zinkina-Orikhan A.V.
Influence of ABCB1 3435C>T polymorphism on methotrexate safety in patients with psoriasis
Kubanov A.A., Asoskova A.V., Zastrozhin M.S., Sozaeva Z.A., Sychev D.A.
Disorders of the skin microbiome in atopic dermatitis and psoriasis
Nikolaeva M.Y., Monakhov K.N., Sokolovskiy E.V.
Epidemiology of psoriasis in the Russian Federation according to the patient registry
Kubanov A.A., Bogdanova E.V.
Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice
Bakulev A.L., Pritulo O.A., Kuntsevich Z.S., Khotko A.A., Yunovidova A.A., Gorognichev P.V., Ziganshin O.R., Rudneva N.S., Bildyuk E.V., Repina T.V., Dudko V.Y., Maksimova M.D.
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
Puig L., Bakulev A.L., Kokhan M.M., Samtsov A.V., Khairutdinov V.R., Morozova M.A., Zolkin N.A., Kuryshev I.V., Petrov A.N., Artemeva A.V., Zinkina-Orikhan A.V.
Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade
Chikin V.V.
Comprehensive assessment of the dynamics of angiogenesis in patients with psoriasis treated with methotrexate
Pritulo O.A., Petrov A.A.
The age at first cutaneous manifestation of psoriasis as a prognostic factor in the timing of psoriatic arthritis diagnosis
Bogdanova E.V.
Assessment of CLA+T-cell subpopulations in the blood of patients with chronic dermatoses
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Soukharev A.V., Gumilevskaya O.P., Sukhina I.A.
Precision therapy for psoriasis patients
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Psoriasis incidence and prevalence in the Russian Federation
ZNAMENSKAYA L.F., MELEKHINA L.Y., BOGDANOVA Y.V., MINEYEVA A.A.
Psoriatic onychodystrophy: indices for assessing the severity of psoriatic onychodystrophy (part 2)
Platonova A.V., Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
Sidorcika T.G., Linovs V.A., Radzina M.A., Rubins A.J., Rubins S.A.
Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis
Bakulev A.L.
Problems with differential diagnostics of seborrheic dermatitis and plaque psoriasis by the exampleof a particular case study
Samtsov A.V., SAMTSOV A.V.
Affected skin examination in psoriatic patients in the courseof Infliximab therapy (a morphologic analysis)
Katunina O.R., Znamenskaya L.F., Matushevskaya Y.I., Katunina O.R., Znamenskaya L.F., Matushevskaya Y.I.
Efficacy of repeated treatment courses of lactulose as a component of complex therapy in patients with psoriasis
Matusevich S.L., Medvedeva I.V.
Ademetionine in the cytostatic treatment of psoriasis
UGRYUMOVA Y.V.
Studying of relationship of Histocompatibility antigens and N-acetylation phenotype in patients of Uzbek populations with psoriasis
IBRAGIMOV S.I., MANSUROVA G.T., MAMATKULOV U.A., MAKHSUDOV M.R.
Inhibitors of tumor necrosis factor-alpha for treatment ofpsoriatic patients
Znamenskaya L.F., Znamenskaya L.F.
TLR - possible molecular target for biologic psoriasis therapy
Katunina O.R., Rezaykina A.V.
Experience of treatment of psoriatic patients with monochromic ultraviolet light from excimer lamps in a combination with external drugs
NEMCHANINOVA O.B.
Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
Olisova O.Y., Svistunova D.A., Chernyavskaya L.M., Anpilogova E.M.
Features of treatment of patients with psoriasis with metabolic syndrome
Khairutdinov V.R., Samtsov A.V.
SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)
Namazova-Baranova L.S., Murashkin N.N., Ambarchyan E.T., Materikin A.I.
Strategy “treat to target” for patients with psoriasis. Relevant issues to biological therapy persistence
Bakulev A.L.
Personalization of an anti-cytokine therapy of psoriatic patients
Kubanov A.A., Svishchenko S.I.
The new external drug for the treatment of psoriasis based on inhibition of serine proteases
Zhukov A.S., Zharun E.R., Khairutdinov V.R., Samtsov A.V., Krasavin M.Y., Garabagiou A.V.
Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19
Kubanov A.A., Bakulev A.L., Kokhan M.M., Olisova O.Y., Samtsov A.V., Sokolovskiy E.V., Khairutdinov V.R., Khobeish M.M.
Changes in the hormonal status of patients with focal psoriasis vulgaris
Vasil'ev A.G., Zaslavskiy D.V., Trashkov A.P., Kravtsova A.A., Kazikhanova S.R., Khayrutdinov V.R., Khvedelidze M.G., VASILIYEV A.G., ZASLAVSKY D.V., TRASHKOV A.P., KRAVTSOVA A.A., KAZIKHANOVA S.R., KHAIRUTDINOV V.R., KHVEDELIDZE M.G.
Proteome technologies in studying the pathogenesisof psoriasis
Znamenskaya L.F., Znamenskaya L.F.
Mechanism of the biological effect of the tumor necrosis factor-аlpha at psoriasis
ZNAMENSKAYA L.F., YEGOROVA Y.Y., ZITNER S.V.
Modern treatment methods for patients with psoriasis
Znamenskaya L.F., Yakovleva S.V., Volnukhin V.A., Pirogova E.V.
Molecular Markers In Forecasting The Clinical Efficacy Of Infliximab In Psoriasis Patients
KUBANOVA A.A., LESNAYA I.N., FRIGO N.V., KAGANOVA N.L., ZNAMENSKAYA L.F., KUBANOV A.A.
A study of the efficacy of using the Kartalin ointment in a complex with exogenous melatonin for psoriasis
DMITRUK V.S., MARTYNOVA V.G., KAMYSHNIKOVA O.A., DMITRUK S.I.
Study of the genetic factors predisposing to the development of psoriasis
MINEEVA A.A., KOZHUSHNAYA O.S., VOLNUKHIN V.A., FRIGO N.V., ZNAMENSKAYA L.F., KUBANOV A.A., MELEKHINA L.E.
Assessment of the efficacy of Betamethasone with Calcipotriol for isolated psoriatic nail affections based on optical coherent tomography
Neznakhina M.S., Petrova G.A., Garanina O.Y., Shlivko I.L.
Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis
Kubanov A.A., Bakulev A.L., Samtsov A.V., Khairutdinov V.R., Sokolovskiy E.V., Kokhan M.M., Artemyeva A.V., Chernyaeva E.V., Ivanov R.A.
Psoriasis: clinical and epidemiological features and therapy issues
Bakulev A.L., Fitileva T.V., Novodezerkina E.А., Gilloteau I., Tian Н., Howe T., Pietri G.
ASSOCIATED PATHOLOGY: CLINICAL ОBSERVATION
Tlish M.M., Popovskayа E.B., Sycheva N.L., Sorokina N.V., Psavok F.A.
Chronic inflammation, insulin resistance, psoriasis - which have in common?
Rasin M.S.
Influence of natural factors Saki lake combined with “Berlition® 600” (Thioctic acidi) on immunoregulatory processes taking into account morphological changes of skin in patients with plaque psoriasis
Kuznetsova M.Y., Pritulo O.A., Prokhorov D.V.
Inflammation and itching in patients suffering from atopic dermatitis and psoriasis. Assessment of the expression of neurotrophins аnd neuropeptides
Smolyannikova V.A., Kubanova A.A., Chikin V.V., Karamova A.E.
Clinical evidence of therapy for genital psoriasis by biologic agents
Sokolovskiy E.V., Kokhan M.M.
Vulgar psoriasis and squamous cell carcinoma in a patient with discoid lupus erythematosus
Dubensky V.V., Nekrasova E.G., Alexandrova O.A., Muraveva E.S.
The role of T-regulatory cells in the pathogenesis of psoriasis
Khayrutdinov V.R., Mikhaylichenko A.F., Mukhina M.S., Samtsov A.V., Imyanitov E.N., Ivanov A.M., KHAIRUTDINOV V.R., MICHAILICHENCO A.F., MUKHINA M.A., SAMTSOV A.V., IMYANITOV E.N., IVANOV A.M.
A case study: combination of pemphigus foliaceus and psoriasis. Problems of diagnostics
NADGERIYEVA O.V., ZNAMENSKAYA L.F., AVDIYENKO I.N., KATUNINA O.R., MURUZOVA I.V.
Role of recognizing receptors in the initiation of immune inflammation in theskin of psoriasis patients
Katunina O.R., Rezaikina A.V., Kolykhalova O.I.
Clinical, molecular and genetic studies of efficacy and safety of using UV irradiation for psoriasis patients
Zhilova M.B., Kubanov A.A., Lesnaya I.N., Frigo N.V., Volkov I.A., Znamenskaya L.F., Volnukhin V.A.
Use of Skin-Cap (activated zinc pyrithione) in the therapy of chronic dermatoses
Study of the genetic factors predisposing to the development of psoriasis
LVOV A.N., KATUNINA O.R., ZNAMENSKAYA L.F., MICHENKO A.V., EGOROVA Y.Y., INOYATOVA L.A., HAIRULLIN R.F., VOLKOV I.A.
Pathogenic value of neuropeptides and growth factor proteins for the development of inflammation and itching in patients with prevalent dermatoses
CHIKIN V.V., ROTANOV S.V., KHAIRULLIN R.F., ZNAMENSKAYA L.F., VAKHITOVA I.I., INOYATOVA L.A.
Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
Kubanov A.A., Bakulev A.L., Gluzmin M.I., Kokhan M.M., Kruglova L.S., Rudneva N.S., Olisova O.Y., Sokolovsky E.V., Khobeish M.M.
Prevalence of chronic infection foci in patients with dermatoses
Patrushev A.V., Samtsov A.V., Ivanov A.M., Sukharev A.V., Asfendiarov D.D.
ACRODERMATITIS CONTINUA SUPPURATIVA HALLOPEAU IN COMBINATION WITH LOCALIZED PSORIASIS VULGARIS
Sokolovskiy E.V., Mikheev G.N.,  Gordeeva A.A.
Anti-cytokine therapy of a patient suffering from psoriatic arthritis
Onipchenko V.V., Sergeeva I.G., Krinitsyina Y.M., Kondrashova A.A., Pahomova V.V., Hismatulina N.V.
A case of generalized pustular psoriasis
Oklopkov V.A., Pravdina O.V., Chermoschentsev A.A., Repina T.V., Poleshuk E.I., Gudoshnik V.G., Gorodilov R.V.
Prevalence of genetic risk factors of psoriasis among the population of the Russian Federation
Kubanov A.A., Kubanova A.A., Karamova A.E., Mineyeva A.A.
Perspective trends of topical therapy of patients with psoriasis
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Comparative study of anti-inflammatory activity of zinc pyrition on a psoriasis laboratory model
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Immunohistochemical analysis of molecular cell structures of genetic and adaptive immunityin patients suffering from psoriasis in the course of biological therapy
Katunina O.R., KATUNINA O.R.
Evaluation of the efficacy of introduction of a new medical technology fortreatment of chronic dermatoses based on the application of activated zincpyrithione
Kubanov A.A., Petrovsky F.I.
Personalized approach to the selection of therapy for patients with psoriasisbased on the results of molecular and genetic tests
Znamenskaya L.F., Frigo N.V., Rotanov S.V., Volkov I.A., Volnukhin V.A., Zhilova M.B.
Assessment of the cytokine profile in psoriasis patients against the background of an immune-modulating therapy
OKHLOPKOV V.A., MEDVEDCHIKOV E.K., DOLGIKH T.I., PRAVDINA O.V., GORODILOV R.V., ZARAYEVA I.F.
Possibility to use Ademetionine for the treatment of psoriaticpatients with a pathology of the hepatobiliary system
Matusevich S.L., Medvedeva I.V., Matusevich S.L., Medvedeva I.V.
Capabilities of the basic treatment preparations in the combined treatment of psoriasis
Hobeysh M.M., Monakhov K.N., Sokolovsky E.V.
First clinical experience of the use of ustekinumab (Stelara) for treatment of psoriatic patients in Russia
Znamenskaya L.F., Svishchenko S.I.
Melanocytic nevi in psoriasis patients: results of a study with the use of dermatoscopy
Sergeyeva I.G., Krinitsyna Y.M., Onipchenko V.V., Makarova N.G.
Distribution of melanocytes in the skin of psoriasis patients
Zhukov A.S., Khairutdinov V.R., Belousova I.E., Samtsov A.V.
Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor
Kungurov N.V., Zilberberg N.V., Kokhan M.M., Keniksfest J.V., Grishaeva E.V.
Origin, function and role in the development of skin diseases CLA+T-lymphocytes
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Ivanov A.М., Gumilevskaya O.Р., Sukharev A.V., Sukhina I.A.
Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients
Bakulev A.L.
PASI (Psoriasis Area and Severity Index) in the evaluation of the clinical manifestations of psoriasis
Kubanov A.A., Karamova A.E., Znamenskaya L.F., Chikin V.V., Kondrashova V.V.
ISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS IN PATIENT SUFFERING FROM PLAQUE PSORIASIS: A CASE REPORT
Znamenskaya L.F., Chikin V.V., Kappusheva I.A., Kondrasheva V.V.
Pathogenic aspects of treatment of psoriatic patients
Chikin V.V., Znamenskaya L.F., Mineyeva A.A.
Features of the cytokine profile and the effectiveness of radical treatment of focal infection in patients with psoriasis
Patrushev A.V., Samtsov A.V., Soukharev A.V.
The Actual Challenges of Biologics Treatment in Patients with Psoriasis
Bakulev A.L.
Markers of efficacy of Infliximab in psoriasis patients
Kubanova A.A., Znamenskaya L.F., Frigo N.V., Volkov I.A., Rotanov S.V., Rezaykina A.V., KUBANOVA A.A., ZNAMENSKAYA L.F., FRIGO N.V., VOLKOV I.A., ROTANOV S.V., REZAIKINA A.V.
Clobetasol propionate (Dermovate) gives new opportunities in the treatment ofdermatoses
Khlebnikova A.N.
Efficacy and safety of treatment of patients suffering from severe forms of psoriasis
BAKULEV A.L., KRAVCHENYA S.S., SLESARENKO N.A., SHABOGINA A.A.
Search for potential biomarkers of inveterate dermatoses by means of proteomic analysis
BRATSEVA Y.V., MOSHKOVSKY S.A., ZNAMENSKAYA L.F., KUBANOVA A.A., KUBANOV A.A.
Immune mechanisms of psoriasis. New strategies of biotherapy
KUBANOVA A.A., KUBANOV A.A., NIKOLAS J.F., PUIG L., PRINCE J., KATUNINA O.R., ZNAMENSKAYA L.F.
Biological therapy of patients with severe psoriasis
NV KUNGUROV M.K., KENICKSFEST Y.V., Keniksfest Y.V.
Pharmacoeconomic aspects of treatment of psoriasis with biological drugs
Rudakova A.V., Kubanov A.A.
Association of polymorphisms in TNFAIP3 and TNIPI genes with predisposition to the development of psoriasis in the Russian population
KUBANOV A.A., KOZHUSHNAYA O.S., FRIGO N.V., MINEYEVA A.A., ZNAMENSKAYA L.F., CHIKIN V.V.
1 - 100 of 153 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies